{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:47:27Z","timestamp":1794970047959,"version":"4.9.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["CC2081"],"award-info":[{"award-number":["CC2081"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["CC2081"],"award-info":[{"award-number":["CC2081"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["317609\/Z\/24\/Z"],"award-info":[{"award-number":["317609\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CC2081"],"award-info":[{"award-number":["CC2081"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Slow growth rates are considered a hallmark of\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    (Mtb) and have been historically associated with persistence and subsequent drug tolerance. Despite the fundamental role intracellular growth plays in the pathogenesis of tuberculosis (TB), approaches that define intracellular growth rates have remained challenging. Here, we developed a high-throughput, live-cell imaging approach to quantify Mtb replication within human macrophage populations at high spatiotemporal, single-cell resolution. Unexpectedly, we discovered fast-growing intracellular Mtb populations with doubling times below 10\u2009hours. Importantly, when treated with first-line antibiotics, these intracellular fast-growing subpopulations remained. To validate this in vivo, we developed a mouse model of tuberculosis featuring a Mtb-Timer fluorophore that reports replication activity. Single-cell analysis revealed a strong correlation between heavily burdened host cells and Mtb populations with heightened replicative activity. These data identify fast-growing intracellular bacteria as a mechanism of antibiotic evasion and challenges the prevailing idea that attributes antibiotic tolerance to bacterial dormancy.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-75915-8","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:23:01Z","timestamp":1785241381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fast-growing intracellular Mycobacterium tuberculosis populations evade antibiotic treatment"],"prefix":"10.1038","volume":"17","author":[{"given":"Nathan J.","family":"Day","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Pradel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-2257","authenticated-orcid":false,"given":"Chak Hon","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-3425","authenticated-orcid":false,"given":"Pierre","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9937-8545","authenticated-orcid":false,"given":"Antony","family":"Fearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beren","family":"Aylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2776-4118","authenticated-orcid":false,"given":"Laure","family":"Botella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Vaubourgeix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ortiz Canseco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Athanasiadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3199-0337","authenticated-orcid":false,"given":"Maximiliano G.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"75915_CR1","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.rmed.2006.08.006","volume":"100","author":"TM Daniel","year":"2006","unstructured":"Daniel, T. M. The history of tuberculosis. Respir. Med. 100, 1862\u20131870 (2006).","journal-title":"Respir. Med."},{"key":"75915_CR2","unstructured":"WHO. Global Tuberculosis Report 2025. Geneva, World Health Organization (2025)."},{"key":"75915_CR3","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa2033400","volume":"384","author":"SE Dorman","year":"2021","unstructured":"Dorman, S. E. et al. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N. Engl. J. Med. 384, 1705\u20131718 (2021).","journal-title":"N. Engl. J. Med."},{"key":"75915_CR4","first-page":"S231","volume":"3","author":"W Fox","year":"1999","unstructured":"Fox, W., Ellard, G. A. & Mitchison, D. A. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J. Tuberc. Lung Dis. 3, S231\u2013S279 (1999).","journal-title":"Int J. Tuberc. Lung Dis."},{"key":"75915_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","volume":"20","author":"VA Dartois","year":"2022","unstructured":"Dartois, V. A. & Rubin, E. J. Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat. Rev. Microbiol. 20, 685\u2013701 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"75915_CR6","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1371\/journal.pmed.0040120","volume":"4","author":"LE Connolly","year":"2007","unstructured":"Connolly, L. E., Edelstein, P. H. & Ramakrishnan, L. Why is long-term therapy required to cure tuberculosis? PLoS Med. 4, e120 (2007).","journal-title":"PLoS Med."},{"key":"75915_CR7","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1128\/IAI.71.12.7099-7108.2003","volume":"71","author":"G Kaplan","year":"2003","unstructured":"Kaplan, G. et al. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect. Immun. 71, 7099\u20137108 (2003).","journal-title":"Infect. Immun."},{"key":"75915_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41579-022-00721-0","volume":"20","author":"ES Chung","year":"2022","unstructured":"Chung, E. S., Johnson, W. C. & Aldridge, B. B. Types and functions of heterogeneity in mycobacteria. Nat. Rev. Microbiol 20, 529\u2013541 (2022).","journal-title":"Nat. Rev. Microbiol"},{"key":"75915_CR9","doi-asserted-by":"publisher","unstructured":"Dhar, N., McKinney, J. & Manina, G. Phenotypic Heterogeneity in Mycobacterium tuberculosis. Microbiol. Spectr. 4 https:\/\/doi.org\/10.1128\/microbiolspec.TBTB2-0021-2016 (2016).","DOI":"10.1128\/microbiolspec.TBTB2-0021-2016"},{"key":"75915_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24127-3","volume":"12","author":"P Santucci","year":"2021","unstructured":"Santucci, P. et al. Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide. Nat. Commun. 12, 3816 (2021).","journal-title":"Nat. Commun."},{"key":"75915_CR11","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1126\/science.aat9689","volume":"364","author":"DJ Greenwood","year":"2019","unstructured":"Greenwood, D. J. et al. Subcellular antibiotic visualization reveals a dynamic drug reservoir in infected macrophages. Science 364, 1279\u20131282 (2019).","journal-title":"Science"},{"key":"75915_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00529-6","volume":"7","author":"G Aljayyoussi","year":"2017","unstructured":"Aljayyoussi, G. et al. Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration. Sci. Rep. 7, 502 (2017).","journal-title":"Sci. Rep."},{"key":"75915_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/BF01964420","volume":"10","author":"PM Tulkens","year":"1991","unstructured":"Tulkens, P. M. Intracellular distribution and activity of antibiotics. Eur. J. Clin. Microbiol Infect. Dis. 10, 100\u2013106 (1991).","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"key":"75915_CR14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1128\/AAC.50.3.841-851.2006","volume":"50","author":"M Barcia-Macay","year":"2006","unstructured":"Barcia-Macay, M., Seral, C., Mingeot-Leclercq, M. P., Tulkens, P. M. & Van Bambeke, F. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob. Agents Chemother. 50, 841\u2013851 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"75915_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm.1915","volume":"15","author":"WP Gill","year":"2009","unstructured":"Gill, W. P. et al. A replication clock for Mycobacterium tuberculosis. Nat. Med. 15, 211\u2013214 (2009).","journal-title":"Nat. Med."},{"key":"75915_CR16","doi-asserted-by":"publisher","unstructured":"Sarathy, J. P. et al. Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum. Antimicrob. Agents Chemother. 62, https:\/\/doi.org\/10.1128\/AAC.02266-17 (2018).","DOI":"10.1128\/AAC.02266-17"},{"key":"75915_CR17","doi-asserted-by":"publisher","first-page":"e00100","DOI":"10.1128\/mBio.00100-11","volume":"2","author":"I Keren","year":"2011","unstructured":"Keren, I., Minami, S., Rubin, E. & Lewis, K. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio 2, e00100\u2013e00111 (2011).","journal-title":"mBio"},{"key":"75915_CR18","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1128\/AAC.40.10.2296","volume":"40","author":"D Herbert","year":"1996","unstructured":"Herbert, D. et al. Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 40, 2296\u20132299 (1996).","journal-title":"Antimicrob. Agents Chemother."},{"key":"75915_CR19","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.4049\/jimmunol.170.4.1939","volume":"170","author":"L Tailleux","year":"2003","unstructured":"Tailleux, L. et al. Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells. J. Immunol. 170, 1939\u20131948 (2003).","journal-title":"J. Immunol."},{"key":"75915_CR20","doi-asserted-by":"publisher","unstructured":"Mahamed, D. et al. Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells. Elife 6, https:\/\/doi.org\/10.7554\/eLife.22028 (2017).","DOI":"10.7554\/eLife.22028"},{"key":"75915_CR21","doi-asserted-by":"publisher","first-page":"e1003190","DOI":"10.1371\/journal.ppat.1003190","volume":"9","author":"T Repasy","year":"2013","unstructured":"Repasy, T. et al. Intracellular bacillary burden reflects a burst size for Mycobacterium tuberculosis in vivo. PLoS Pathog. 9, e1003190 (2013).","journal-title":"PLoS Pathog."},{"key":"75915_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01846-z","author":"ES Chung","year":"2024","unstructured":"Chung, E. S., Kar, P., Kamkaew, M., Amir, A. & Aldridge, B. B. Single-cell imaging of the Mycobacterium tuberculosis cell cycle reveals linear and heterogenous growth. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-024-01846-z (2024).","journal-title":"Nat. Microbiol."},{"key":"75915_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-0716-3890-3_12","volume":"2813","author":"C Toniolo","year":"2024","unstructured":"Toniolo, C., Sage, D., McKinney, J. D. & Dhar, N. Quantification of Mycobacterium tuberculosis Growth in Cell-Based Infection Assays by Time-Lapse Fluorescence Microscopy. Methods Mol. Biol. 2813, 167\u2013188 (2024).","journal-title":"Methods Mol. Biol."},{"key":"75915_CR24","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1016\/j.bmcl.2013.07.006","volume":"23","author":"V Dartois","year":"2013","unstructured":"Dartois, V. & Barry, C. E. 3rd A medicinal chemists\u2019 guide to the unique difficulties of lead optimization for tuberculosis. Bioorg. Med. Chem. Lett. 23, 4741\u20134750 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"75915_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.tim.2023.08.009","volume":"32","author":"NJ Day","year":"2024","unstructured":"Day, N. J., Santucci, P. & Gutierrez, M. G. Host cell environments and antibiotic efficacy in tuberculosis. Trends Microbiol 32, 270\u2013279 (2024).","journal-title":"Trends Microbiol"},{"key":"75915_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48269-2","volume":"15","author":"M Mistretta","year":"2024","unstructured":"Mistretta, M. et al. Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy. Nat. Commun. 15, 4175 (2024).","journal-title":"Nat. Commun."},{"key":"75915_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-02217-y","author":"A Jovanovic","year":"2026","unstructured":"Jovanovic, A. et al. Large-scale testing of antimicrobial lethality at single-cell resolution predicts mycobacterial infection outcomes. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-025-02217-y (2026).","journal-title":"Nat. Microbiol"},{"key":"75915_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymeth.2019.06.016","volume":"164-165","author":"WC Skarnes","year":"2019","unstructured":"Skarnes, W. C., Pellegrino, E. & McDonough, J. A. Improving homology-directed repair efficiency in human stem cells. Methods 164-165, 18\u201328 (2019).","journal-title":"Methods"},{"key":"75915_CR29","doi-asserted-by":"publisher","unstructured":"Bernard, E. M. et al. M. tuberculosis infection of human iPSC-derived macrophages reveals complex membrane dynamics during xenophagy evasion. J. Cell Sci. 134 https:\/\/doi.org\/10.1242\/jcs.252973 (2020).","DOI":"10.1242\/jcs.252973"},{"key":"75915_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1083\/jcb.201603040","volume":"216","author":"TR Lerner","year":"2017","unstructured":"Lerner, T. R. et al. Mycobacterium tuberculosis replicates within necrotic human macrophages. J. Cell Biol. 216, 583\u2013594 (2017).","journal-title":"J. Cell Biol."},{"key":"75915_CR31","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/jac\/dkg446","volume":"52","author":"Y Zhang","year":"2003","unstructured":"Zhang, Y., Wade, M. M., Scorpio, A., Zhang, H. & Sun, Z. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J. Antimicrob. Chemother. 52, 790\u2013795 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"75915_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/rr54","volume":"2","author":"A Somoskovi","year":"2001","unstructured":"Somoskovi, A., Parsons, L. M. & Salfinger, M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res. 2, 164\u2013168 (2001).","journal-title":"Respir. Res."},{"key":"75915_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/antibiotics3030317","volume":"3","author":"JC Palomino","year":"2014","unstructured":"Palomino, J. C. & Martin, A. Drug Resistance Mechanisms in Mycobacterium tuberculosis. Antibiotics (Basel) 3, 317\u2013340 (2014).","journal-title":"Antibiotics (Basel)"},{"key":"75915_CR34","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","volume":"74","author":"WS Cleveland","year":"1979","unstructured":"Cleveland, W. S. Robust Locally Weighted Regression and Smoothing Scatterplots. J. Am. Stat. Assoc. 74, 829\u2013836 (1979).","journal-title":"J. Am. Stat. Assoc."},{"key":"75915_CR35","unstructured":"Sofroniew, N. L. et al. napari: a multi-dimensional image viewer for Python, https:\/\/github.com\/napari\/napari (2019)."},{"key":"75915_CR36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/01621459.1995.10476572","volume":"90","author":"RE Kass","year":"1996","unstructured":"Kass, R. E. & Raftery, A. E. Bayes Factors. J. Am. Stat. Assoc. 90, 773\u2013795 (1996).","journal-title":"J. Am. Stat. Assoc."},{"key":"75915_CR37","doi-asserted-by":"publisher","unstructured":"Campo-Perez, V., Luk, C. H., Botella, L., Vaubourgeix, J. & Gutierrez, M. G. Mtb-Timer: a fluorescent reporter to visualize Mycobacterium tuberculosis replication and antibiotic responses. mSystems, e0179625, https:\/\/doi.org\/10.1128\/msystems.01796-25 (2026).","DOI":"10.1128\/msystems.01796-25"},{"key":"75915_CR38","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.cell.2014.06.045","volume":"158","author":"B Claudi","year":"2014","unstructured":"Claudi, B. et al. Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell 158, 722\u2013733 (2014).","journal-title":"Cell"},{"key":"75915_CR39","doi-asserted-by":"publisher","first-page":"e1009550","DOI":"10.1371\/journal.ppat.1009550","volume":"17","author":"CH Luk","year":"2021","unstructured":"Luk, C. H. et al. Salmonella enters a dormant state within human epithelial cells for persistent infection. PLoS Pathog. 17, e1009550 (2021).","journal-title":"PLoS Pathog."},{"key":"75915_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1021\/acsinfecdis.5b00127","volume":"2","author":"SM Irwin","year":"2016","unstructured":"Irwin, S. M. et al. Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB\/FeJ Mice. ACS Infect. Dis. 2, 251\u2013267 (2016).","journal-title":"ACS Infect. Dis."},{"key":"75915_CR41","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1128\/AAC.00217-12","volume":"56","author":"ER Driver","year":"2012","unstructured":"Driver, E. R. et al. Evaluation of a mouse model of necrotic granuloma formation using C3HeB\/FeJ mice for testing of drugs against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56, 3181\u20133195 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"75915_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"75915_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1242\/dmm.019513","volume":"8","author":"JP Lanoix","year":"2015","unstructured":"Lanoix, J. P., Lenaerts, A. J. & Nuermberger, E. L. Heterogeneous disease progression and treatment response in a C3HeB\/FeJ mouse model of tuberculosis. Dis. Model Mech. 8, 603\u2013610 (2015).","journal-title":"Dis. Model Mech."},{"key":"75915_CR44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20172020","volume":"215","author":"L Huang","year":"2018","unstructured":"Huang, L., Nazarova, E. V., Tan, S., Liu, Y. & Russell, D. G. Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. J. Exp. Med. 215, 1135\u20131152 (2018).","journal-title":"J. Exp. Med."},{"key":"75915_CR45","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.chom.2024.04.015","volume":"32","author":"A Amoura","year":"2024","unstructured":"Amoura, A. et al. Variability in cell division among anatomical sites shapes Escherichia coli antibiotic survival in a urinary tract infection mouse model. Cell Host Microbe 32, 900\u2013912.e904 (2024).","journal-title":"Cell Host Microbe"},{"key":"75915_CR46","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.chom.2024.04.019","volume":"32","author":"S Helaine","year":"2024","unstructured":"Helaine, S., Conlon, B. P., Davis, K. M. & Russell, D. G. Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics. Cell Host Microbe 32, 852\u2013862 (2024).","journal-title":"Cell Host Microbe"},{"key":"75915_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0520-1","volume":"15","author":"A Koch","year":"2014","unstructured":"Koch, A. & Wilkinson, R. J. The road to drug resistance in Mycobacterium tuberculosis. Genome Biol. 15, 520 (2014).","journal-title":"Genome Biol."},{"key":"75915_CR48","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/jam.14478","volume":"128","author":"R Singh","year":"2020","unstructured":"Singh, R. et al. Recent updates on drug resistance in Mycobacterium tuberculosis. J. Appl. Microbiol. 128, 1547\u20131567 (2020).","journal-title":"J. Appl. Microbiol."},{"key":"75915_CR49","doi-asserted-by":"publisher","unstructured":"Lapinska, U. et al. Fast bacterial growth reduces antibiotic accumulation and efficacy. Elife 11, https:\/\/doi.org\/10.7554\/eLife.74062 (2022).","DOI":"10.7554\/eLife.74062"},{"key":"75915_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s44259-025-00180-6","volume":"4","author":"Y Miyahara","year":"2026","unstructured":"Miyahara, Y. et al. Survival of ampicillin-treated uropathogenic Escherichia coli is independent of single-cell growth rates. NPJ Antimicrob. Resist 4, 7 (2026).","journal-title":"NPJ Antimicrob. Resist"},{"key":"75915_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/mdr.1997.3.277","volume":"3","author":"LE Bermudez","year":"1997","unstructured":"Bermudez, L. E. & Inderlied, C. B. Effect of Mycobacterium avium infection on the influx, accumulation, and efflux of KRM-1648 by human macrophages. Micro. Drug Resist. 3, 277\u2013282 (1997).","journal-title":"Micro. Drug Resist."},{"key":"75915_CR52","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41429-021-00462-x","volume":"74","author":"RA Adams","year":"2021","unstructured":"Adams, R. A. et al. Rifamycin antibiotics and the mechanisms of their failure. J. Antibiot. (Tokyo) 74, 786\u2013798 (2021).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"75915_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06667-3","volume":"9","author":"JH Zhu","year":"2018","unstructured":"Zhu, J. H. et al. Rifampicin can induce antibiotic tolerance in mycobacteria via paradoxical changes in rpoB transcription. Nat. Commun. 9, 4218 (2018).","journal-title":"Nat. Commun."},{"key":"75915_CR54","doi-asserted-by":"publisher","first-page":"046001","DOI":"10.1088\/1478-3975\/ab131e","volume":"16","author":"P Sinclair","year":"2019","unstructured":"Sinclair, P., Carballo-Pacheco, M. & Allen, R. J. Growth-dependent drug susceptibility can prevent or enhance spatial expansion of a bacterial population. Phys. Biol. 16, 046001 (2019).","journal-title":"Phys. Biol."},{"key":"75915_CR55","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/jac\/dkm485","volume":"61","author":"PC Karakousis","year":"2008","unstructured":"Karakousis, P. C., Williams, E. P. & Bishai, W. R. Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 61, 323\u2013331 (2008).","journal-title":"J. Antimicrob. Chemother."},{"key":"75915_CR56","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1086\/605605","volume":"200","author":"Z Ahmad","year":"2009","unstructured":"Ahmad, Z. et al. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig. J. Infect. Dis. 200, 1136\u20131143 (2009).","journal-title":"J. Infect. Dis."},{"key":"75915_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00659-22","volume":"13","author":"N Ojkic","year":"2022","unstructured":"Ojkic, N., Serbanescu, D. & Banerjee, S. Antibiotic Resistance via Bacterial Cell Shape-Shifting. mBio 13, e0065922 (2022).","journal-title":"mBio"},{"key":"75915_CR58","doi-asserted-by":"publisher","unstructured":"Mishra, R. et al. Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis. Sci. Transl. Med. 11, https:\/\/doi.org\/10.1126\/scitranslmed.aaw6635 (2019).","DOI":"10.1126\/scitranslmed.aaw6635"},{"key":"75915_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.1229858","volume":"339","author":"Y Wakamoto","year":"2013","unstructured":"Wakamoto, Y. et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science 339, 91\u201395 (2013).","journal-title":"Science"},{"key":"75915_CR60","doi-asserted-by":"publisher","unstructured":"Lamont, E. A., Dillon, N. A. & Baughn, A. D. The Bewildering Antitubercular Action of Pyrazinamide. Microbiol. Mol. Biol. Rev. 84, https:\/\/doi.org\/10.1128\/MMBR.00070-19 (2020).","DOI":"10.1128\/MMBR.00070-19"},{"key":"75915_CR61","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1128\/JB.181.7.2044-2049.1999","volume":"181","author":"Y Zhang","year":"1999","unstructured":"Zhang, Y., Scorpio, A., Nikaido, H. & Sun, Z. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J. Bacteriol. 181, 2044\u20132049 (1999).","journal-title":"J. Bacteriol."},{"key":"75915_CR62","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/acsinfecdis.7b00079","volume":"3","author":"P Gopal","year":"2017","unstructured":"Gopal, P. et al. Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD. ACS Infect. Dis. 3, 807\u2013819 (2017).","journal-title":"ACS Infect. Dis."},{"key":"75915_CR63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nbt.2021.02.003","volume":"63","author":"V Campo-Perez","year":"2021","unstructured":"Campo-Perez, V., Cendra, M. D. M., Julian, E. & Torrents, E. Easily applicable modifications to electroporation conditions improve the transformation efficiency rates for rough morphotypes of fast-growing mycobacteria. N. Biotechnol. 63, 10\u201318 (2021).","journal-title":"N. Biotechnol."},{"key":"75915_CR64","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00117-22","volume":"13","author":"P Santucci","year":"2022","unstructured":"Santucci, P. et al. Visualizing Pyrazinamide Action by Live Single-Cell Imaging of Phagosome Acidification and Mycobacterium tuberculosis pH Homeostasis. mBio 13, e0011722 (2022).","journal-title":"mBio"},{"key":"75915_CR65","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1128\/AAC.03205-14","volume":"58","author":"S Sharma","year":"2014","unstructured":"Sharma, S. et al. Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 58, 5801\u20135808 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"75915_CR66","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.10715850","author":"V Hilsenstein","year":"2022","unstructured":"Hilsenstein, V., Albert, M. & Buckley, G. VolkerH\/DaskFusion: v0.0.1 (v0.0.1). Zenodo https:\/\/doi.org\/10.5281\/zenodo.10715850 (2022).","journal-title":"Zenodo"},{"key":"75915_CR67","unstructured":"Dask. Dask: Library for dynamic task scheduling, http:\/\/dask.pydata.org (2016)."},{"key":"75915_CR68","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41592-022-01663-4","volume":"19","author":"M Pachitariu","year":"2022","unstructured":"Pachitariu, M. & Stringer, C. Cellpose 2.0: how to train your own model. Nat. Methods 19, 1634\u20131641 (2022).","journal-title":"Nat. Methods"},{"key":"75915_CR69","doi-asserted-by":"publisher","unstructured":"Ulicna, K., Vallardi, G., Charras, G. & Lowe, A. R. Automated Deep Lineage Tree Analysis Using a Bayesian Single Cell Tracking Approach. Frontiers in Computer Science 3, https:\/\/doi.org\/10.3389\/fcomp.2021.734559 (2021).","DOI":"10.3389\/fcomp.2021.734559"},{"key":"75915_CR70","unstructured":"Seabold, S. P., Josef. in 9th Python in Science Conference (2010)."},{"key":"75915_CR71","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00418-023-02209-1","volume":"160","author":"J Moore","year":"2023","unstructured":"Moore, J. et al. OME-Zarr: a cloud-optimized bioimaging file format with international community support. Histochem Cell Biol. 160, 223\u2013251 (2023).","journal-title":"Histochem Cell Biol."},{"key":"75915_CR72","unstructured":"Rocklin, M. in Proceedings of the 14th Python in Science Conference. 130\u2013136."},{"key":"75915_CR73","doi-asserted-by":"publisher","unstructured":"Waskom, M. seaborn: statistical data visualization. Journal of Open Source Software 6, https:\/\/doi.org\/10.21105\/joss.03021 (2021).","DOI":"10.21105\/joss.03021"},{"key":"75915_CR74","doi-asserted-by":"publisher","unstructured":"Day, N. macrohet: single-cell trajectory dataset of intracellular Mycobacterium tuberculosis population heterogeneity in iPSC-derived macrophages [Data set]. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.20831464 (2026).","DOI":"10.5281\/zenodo.20831464"},{"key":"75915_CR75","doi-asserted-by":"publisher","unstructured":"Day, N. nthndy\/macrohet: macrohet: Single-cell analysis of intracellular Mycobacterium tuberculosis population heterogeneity in iPSC-derived macrophages (v2.0.0). Zenodo. https:\/\/doi.org\/10.5281\/zenodo.20819399 (2026).","DOI":"10.5281\/zenodo.20819399"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75915-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:03:07Z","timestamp":1787875387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75915-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75915"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75915-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9164"}}